In a footnote of his opinion, Judge Joshua Roberts wrote, “A more cynical view of the circumstances is that plaintiffs’ ...

The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...

The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...

North America severe asthma market is set for growth, driven by high asthma prevalence, increased awareness, and advanced treatment options for severe cases. Ankush Nikam Future Market Insights, Inc.

Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, announced ...

Abingdon-based Oxford Instruments told investors that experienced executive Paul Fry will be appointed as its chief financial ...

Ramos, previously Pfizer's senior vice president and global head of BioTherapeutics R&D, has been appointed to the board of ...

This latest investment, which brings OXcan’s total funding to date to $16.7 million, will be used to develop and globally ...

Read about vaccine sales, Akums and more in the latest Market Talks covering Health Care.

GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

As for GBS itself, this neurological ailment can be severe, attacking nerves and warranting hospitalisation for weeks or ...